• Sun. Apr 14th, 2024

Japanese Company Kobayashi’s Beni-Koji Product Linked to Kidney Disease in Taiwan – What You Need to Know

BySamantha Nguyen

Apr 3, 2024
More Japanese individuals hospitalized due to red yeast rice consumption

On April 1, health authorities in Taiwan reported 11 cases of health problems linked to Kobayashi’s beni-koji, with one individual purchasing the product in Japan. This brought the total number of patients affected by the product to 166. The Japanese Ministry of Health reported that an additional 9 people were hospitalized after using beni-koji red yeast rice from pharmaceutical company Kobayashi.

Kobayashi introduced the product “beni-koji choleste help” in February 2021 and sold approximately one million packs by the end of February this year. However, many users later developed kidney disease. The company identified puberulic acid, a natural compound derived from green mold, in the production of beni-koji. This compound was found to be a potent antibacterial and antimalarial substance that can be toxic to users.

The Food Safety Department advised that these products have not been approved for circulation in Vietnam and warned against purchasing them through social networks. If these products are found in the market, individuals are urged to notify authorities for appropriate action in accordance with the law.

By Samantha Nguyen

As a content writer at newsskio.com, I weave words to craft compelling narratives that captivate readers and bring stories to life. With a keen eye for detail and a passion for storytelling, I strive to create engaging and informative content that resonates with our audience. Whether I'm delving into the latest news trends or exploring unique angles on various topics, my goal is to deliver quality content that informs, entertains, and inspires. Join me on this journey as we uncover the news stories that matter most.

Leave a Reply